News
Nasus Pharma announces positive Results in Naloxone Pivotal Trial.
April 13, 2021
Nasus Pharma Announces Positive Results in Pivotal Trial of FMXIN001 Naloxone Powder-Based Nasal Spray for the Treatment of opioid overdose • Significantly higher rapid absorption
Nasal spray to stop spread of Covid-19? Israeli pharma company puts its product to the test
October 14, 2020
Israeli biopharmaceutical company in process of working on new mist treatment to combat spread of coronavirus in large populations For the full article click here
Nasus Pharma Announces First Clinical Data Demonstrating Efficacy of TaffixTM Intranasal Antiviral Protection Against SARS-CoV-2- in
October 13, 2020
Tel Aviv , Israel, October 13, 2020 – Nasus Pharma a privately held clinical-stagebiopharmaceutical company developing a powder-based intranasal (PBI) productportfolio to address acute medical
More News
A new product – TaffiX ™
August 1, 2020
TaffiX ™ Nasal Powder Spray Device against Viruses, i24
August 1, 2020